deltatrials
Terminated NA NCT01100658

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Effects of Methylphenidate on Neuropsychological Functioning in Children With Attention Deficits Secondary to Childhood Cancer

Sponsor: Children's Cancer Research Fund

Conditions ALL, Childhood Brain Neoplasms, Malignant Brain Tumors Cancer of Brain Cancer of the Brain Leukemia, Lymphoblastic Leukemia, Lymphoblastic, Acute Leukemia, Lymphoblastic, Acute, L1 Leukemia, Lymphoblastic, Acute, L2 Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Leukemia, Lymphocytic, Acute Leukemia, Lymphocytic, Acute, L1 Leukemia, Lymphocytic, Acute, L2 Lymphoblastic Leukemia Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia, Acute, L1 Lymphoblastic Leukemia, Acute, L2 Lymphoblastic Lymphoma Lymphocytic Leukemia, Acute Lymphocytic Leukemia, L1 Lymphocytic Leukemia, L2 Malignant Primary Brain Tumors
Interventions Methylphenidate Placebo
Updated 8 times since 2017 Last updated: Mar 16, 2015 Started: May 31, 2010 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This NA trial investigates ALL, Childhood and Brain Neoplasms, Malignant and is currently terminated or withdrawn. Children's Cancer Research Fund leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

8 versions recorded

  1. May 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — May 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated NA

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

▶ Show 3 earlier versions

  1. Nov 2019 — Jan 2021 [monthly]

    Terminated NA

  2. Jun 2018 — Nov 2019 [monthly]

    Terminated NA

  3. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Cancer Research Fund
  • University of Minnesota
Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Minneapolis, United States